Recombinant binding protein targeting tslp and use thereof
AssigneeJingyuan Biosciences (Suzhou) Co., Ltd.
InventorsXiaobo CHEN, Linghua GUO, Yunqiu YAN, Wenzheng QIAN, Hui CHAI, Minxiang LIU
Life of this patent
Estimating the term…
Loading patent…
AssigneeJingyuan Biosciences (Suzhou) Co., Ltd.
InventorsXiaobo CHEN, Linghua GUO, Yunqiu YAN, Wenzheng QIAN, Hui CHAI, Minxiang LIU
Estimating the term…
Disclosed are a recombinant binding protein targeting TSLP and the use thereof. The recombinant binding protein comprises at least one ankyrin repeat domain that specifically binds to TSLP, wherein the ankyrin repeat domain comprises three tandem binding domains, and each binding domain comprises four binding active regions. The recombinant binding protein of the present invention has excellent binding activity to TSLP, and effectively blocks the interaction between TSLP and a receptor thereof, thereby effectively controlling TSLP-related diseases.
A recombinant binding protein targeting TSLP, comprising at least one ankyrin repeat domain that specifically binds to TSLP;
(canceled)
6-8. (canceled)
(canceled)
(canceled)
A recombinant binding protein targeting TSLP, comprising at least one ankyrin repeat domain that specifically binds to human TSLP;
Dependencies are inferred from the claim text.